Europe news

Jaunajā LZVS pamatsistēmas (Core) relīzē 1.10 ir iestrādāts, ka pie iepakojumu atkārtotas dzēšanas (double scan) tiek limitēts ne tikai atkārtoto darbību skaits, bet arī laika limits, kādā tiek veiktas darbības.

Vēlamies informēt, ka visas tehniskās problēmas ir novērstas un sistēmas darbība ir pilnībā atjaunota.

Vēlamies Jūs informēt, ka pašlaik, no plkst.12.00 LZVS darbība ir traucēta un sistēma nav pieejama.

On May 31, a new Core 1.10 release was deployed into the production environment of the Latvian Medicines Verification System (LZVS).

The unique identifier on that pack should not be decommissioned in the verification system by the end-users – pharmacies, wholesalers, healthcare institutions – if the specific pack has already expired.

EMVO repeatedly reminds to all medicines manufacturers, On-boarding partners (OBP) about the quality of data that uploaded to the EU HUB and further transmitted to the national medicines verification organisations.

In Q1 2022, 26.6 million transactions were made in LZVS, of which 6.2 million were package decommissioning and dispensing. This is 12% more than in the same period last year,